Ventas, Inc. (NYSE:VTR) is a leading real estate investment trust (REIT) that focuses on senior housing and healthcare properties. The company has a diverse portfolio, including senior housing communities, medical office buildings, and hospitals. Ventas competes with other REITs like Welltower and Healthpeak Properties in the healthcare real estate sector.

On February 10, 2026, RBC Capital set a new price target of $91 for VTR, which was trading at $82.79 at the time. This target suggests a potential increase of about 9.92%. The stock's current price is $82.87, showing a slight increase of 0.15% from the previous day. The stock has fluctuated between $82.67 and $83.14 during the trading day.

Ventas reported an "outstanding year" in 2025, driven by its senior housing segment. The company's "1, 2, 3 strategy" focuses on senior housing growth, value-creating investments, and portfolio cash flow. This strategy led to a 9% increase in normalized funds from operations (FFO) per share and a 15% growth in same-store SHOP cash net operating income (NOI).

The company's enterprise value exceeded $50 billion, with fourth-quarter annualized NOI and SHOP NOI reaching $2.5 billion and $1.3 billion, respectively. Ventas owns over 83,000 SHOP units, with 53% of its NOI generated by SHOP communities. The company has increased its quarterly dividend and expects continued growth in 2026, led by its Senior Housing Operating Portfolio (SHOP).